A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

Clinical trial NCT01610687 · COMPLETED

Trial details

NCT number: NCT01610687
Sponsor: Jazz Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis Spasticity

Start date: 2001-07-01
Primary completion: 2005-02-01
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.